A01K 2267/0375
Animal model for cardiovascular diseases
A01K2267/0375 (Animal model for cardiovascular diseases) appears on 198 US grants and 393 published applications in this corpus.
Search patents in A01K- Granted patents
- 198
- Published applications
- 393
- Assignees
- 228
- Inventors
- 948
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 2 | 0 |
| 2001 | 8 | 2 |
| 2002 | 7 | 18 |
| 2003 | 7 | 16 |
| 2004 | 4 | 16 |
| 2005 | 6 | 18 |
| 2006 | 7 | 19 |
| 2007 | 4 | 12 |
| 2008 | 7 | 20 |
| 2009 | 6 | 16 |
| 2010 | 9 | 28 |
| 2011 | 13 | 22 |
| 2012 | 6 | 15 |
| 2013 | 12 | 9 |
| 2014 | 4 | 8 |
| 2015 | 14 | 13 |
| 2016 | 4 | 8 |
| 2017 | 8 | 5 |
| 2018 | 3 | 14 |
| 2019 | 1 | 11 |
| 2020 | 5 | 19 |
| 2021 | 9 | 11 |
| 2022 | 7 | 22 |
| 2023 | 9 | 27 |
| 2024 | 7 | 11 |
| 2025 | 11 | 17 |
| 2026 | 8 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Monocyte-specific aptamers and uses thereof for delivering therapeutic agents to heart11 Aug 2026US 12,702,716 B2Academia Sinica
- TRPV4 receptor ligands11 Aug 2026US 12,703,680 B2University of Utah Research Foundation
- Genetically modified mouse, methods for producing the same, and uses thereof21 Jul 2026US 12,685,297 B2Mackay Memorial Hospital
- Anc80 encoding sphingolipid-metabolizing proteins5 May 2026US 12,618,059 B2Icahn School of Medicine at Mount Sinai
- Synthetic modified RNA and uses thereof21 Apr 2026US 12,606,822 B2Icahn School of Medicine at Mount Sinai
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Cerebral microbleed animal model and preparation method therefor10 Sep 2026US 2026/0262614 A1Ajou University Industry-Academic Cooperation Foundation
- A novel marker for cardiomyocytes dedifferentiation13 Aug 2026US 2026/0235604 A1National University of Singapore
- Use of mutant yap for improving cardiac function6 Aug 2026US 2026/0226115 A1Baylor College of Medicine
- Gene therapy for lemd2 cardiomyopathy25 Jun 2026US 2026/0174900 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Methods for treating conditions associated with MASP-2 dependent complement activation60US 7,919,094 B2Omeros Corporation · 2011
- Transgenic rabbit that expresses a functional human lipoprotein (a)51US 6,512,161 B1Aventis Pharmaceuticals Inc. · 2003
- Targets for treatment of hypercholesterolemia47US 8,512,964 B2The Regents of the University of California · 2013
- PD-1-lacking mouse and use thereof43US 7,414,171 B2Ono Pharmaceutical Co., Ltd. · 2008
- Methods for treating hypercholesterolemia41US 8,084,437 B2Isis Pharmaceuticals, Inc. · 2011